By The ASCO Post Staff Posted: 7/5/2022 12:10:00 PM Last Updated: 7/5/2022 2:32:23 PM Data from the world’s largest prostate cancer screening study provides further evidence to support the introduction of a targeted screening program for the disease, said researchers. In 2009, the European Randomised Study…
Recent research has provided valuable insights into the long-term outcomes of patients with pathogenic BRCA1 and BRCA2 mutations who undergo breast-conserving therapy, according to a…
In a retrospective cohort study (SPOTLIGHT), investigators found that a substantial proportion of patients with unresectable stage III NSCLC did not receive consolidation durvalumab after…
Results from the phase I TROPION-PanTumor01 trial showed that the antibody-drug conjugate datopotamab deruxtecan was active in patients with locally advanced or metastatic hormone receptor…
In a research letter, staff from Royal Brompton Hospital, Guy’s and St. Thomas’ NHS Foundation Trust in London described their experience over 10 years in…
Testing for measurable residual disease (MRD) prior to bone marrow transplant may be effective and practical in patients in remission after receiving treatment for AML,…
Recent research has provided valuable insights into the long-term outcomes of patients with pathogenic BRCA1 and BRCA2 mutations who undergo breast-conserving therapy, according to a…
A novel AI model may accurately predict which patients with cancer may require mental health services during cancer care, according to results from a recent…
Monotherapy with the oral KRAS G12C inhibitor glecirasib demonstrated efficacy in previously treated patients with KRAS G12C–mutated NSCLC, according to data presented during the ASCO…
A single-center phase II trial found that a strategy of premastectomy radiotherapy and immediate breast reconstruction was feasible in patients undergoing surgery for breast cancer.
In a Chinese study, investigators found that sequential CD7 CAR T-cell therapy and allogeneic hematopoietic stem cell transplantation (HSCT) without graft-vs-host disease (GVHD) prophylaxis was…
